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Abstract 
Despite both having some shared features, evidence linking psychosis and adult Attention 
Deficit Hyperactivity Disorder (ADHD) is sparse and inconsistent. Hypotheses tested were 1] 
adult ADHD symptoms are associated with auditory hallucinations, paranoid ideation and 
psychosis 2] links between ADHD symptoms and psychosis are mediated by prescribed ADHD 
medications, use of illicit drugs, and dysphoric mood. The Adult Psychiatric Morbidity Survey 
2007 (N=7403) provided data for regression and multiple mediation analyses. ADHD 
symptoms were coded from the ADHD Self-Report Scale (ASRS). Higher ASRS total score 
was significantly associated with psychosis, paranoid ideation and auditory hallucinations 
despite controlling for socio-demographic variables, verbal IQ, autism spectrum disorder traits, 
childhood conduct problems, hypomanic and dysphoric mood. An ASRS score indicating 
probable ADHD diagnosis was also significantly associated with psychosis. The link between 
higher ADHD symptoms and psychosis, paranoia and auditory hallucinations was significantly 
mediated by dysphoric mood, but not by use of amphetamine, cocaine or cannabis. In 
conclusion, higher levels of adult ADHD symptoms and psychosis are linked and dysphoric 
mood may form part of the mechanism. Our analyses contradict the traditional clinical view 
that the main explanation for people with ADHD symptoms developing psychosis is illicit 
drugs.  
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1. Introduction 
Attention Deficit Hyperactivity Disorder (ADHD) and schizophrenia have both been 
conceptualised as neurodevelopmental disorders (Owen et al., 2011). The defining symptoms 
of ADHD comprise inattention, hyperactivity and impulsivity, and are essentially 
neurodevelopmental arising in early childhood. There is significant persistence of symptoms 
from childhood to adulthood, with consequential social impairment (Barkley et al., 2002). In 
schizophrenia the defining symptoms of delusions, hallucinations and thought disorders 
commonly emerge in youth and in some patients are associated with neurocognitive and 
developmental deficits that precede these psychotic symptoms (Howes and Murray 2014). 
Given that neurocognitive features define the syndrome in ADHD, but are ancillary in 
psychosis, the question of the association between the two syndromes is empirical rather than 
definitional, and may have implications for the nature of both conditions and for mechanisms 
of symptom production.  
So far, evidence for such an association has been sparse, inconsistent and tangential. Ross and 
colleagues (2006) reported that ADHD was the commonest comorbid condition in children and 
adolescents with schizophrenia (Ross et al., 2006). Young relatives of patients with 
schizophrenia have an increased rate of impulsivity, hyperactivity, attentional problems and 
emotional lability (Keshavan et al., 2003). Prospective studies of children with ADHD 
assessing the appearance of psychosis in adulthood are few in number and have led to mixed 
results. In a 10 year follow- up of 140 children diagnosed with ADHD, there was a trend level 
(p=0.057) increase in the hazard of developing psychosis (Biederman et al., 2006). Weiss and 
colleagues found no increased risk of psychosis in adulthood after 15 years in a small group of 
hyperactive children (Weiss et al., 1985). Most recently however, analysis of follow-up data 
from the Danish Psychiatric Register of over 200 children with ADHD suggests an increased 
relative risk (RR: 4.3) of schizophrenia in adulthood (Dalsgaard et al., 2013).  
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There is a degree of overlap in the putative neuropsychological deficits in the two disorders. 
Attention deficits, which are part of the ADHD syndrome, are frequently identified in people 
with schizophrenia (Keshavan et al., 2003). Whilst neuropsychological deficits are generally 
associated with negative symptoms of schizophrenia, ability to sustain and select attention have 
also been strongly associated with positive schizotypal symptoms (Keefe et al., 1997) and 
positive symptoms in schizophrenia (Berman et al., 1997). Impulsivity in ADHD is thought to 
manifest at the motor level through hyperactivity (Rubia 2002). Much less is known about 
impulsivity in schizophrenia, though it is associated with comorbid substance use and 
aggression (Hoptman et al., 2010). 
It is possible that links between ADHD and psychosis might be drug-related effects, whether 
through prescription or abuse. Psychostimulant use for ADHD in children can lead to visual or 
tactile hallucinations (Mosholder et al., 2009). The abuse of methylphenidate is known to cause 
psychotic-like symptoms in adults (Morton and Stockton 2000), an affect related to short term 
or chronic toxicity. Atomoxetine, the noradrenaline reuptake inhibitor prescribed for ADHD 
has been linked with paranoid delusions and mania-like states (Ross 2006), albeit rarely. In 
those with a pre-existing diagnosis of schizophrenia, the use of methylphenidate has been 
shown to worsen the condition (Ekinci and Sabuncuoglu 2011). People with ADHD are also 
more likely to consume illicit drugs known to increase the risk of psychosis, including cannabis 
(Faraone et al., 2007) and psycho-stimulants (McGough et al., 2005). 
An alternative pathway between ADHD symptoms and psychosis might be provided by 
dysphoric mood. Anxiety and depression are strongly comorbid with ADHD (Kessler et al., 
2006) occurring in 40-50% of adults with the condition, and may worsen the symptoms of 
ADHD (Schatz and Rostain 2006). Anxiety and depression have also been highlighted as 
significant factors in cognitive models of psychosis (Garety et al., 2001). They are associated 
with clinical and non-clinical paranoid thinking, and, alongside mood instability, with the 
emergence and persistence of psychosis (Freeman et al., 2013, Marwaha et al., 2014). 
Dysphoric mood may thus provide a mechanism common to both adult ADHD and psychosis. 
If so, the aetiology of affective disturbance may also be shared by both ADHD and psychosis, 
and this would include childhood adversities. Alternatively, the dysphoric or social 
consequences of one condition might drive the emergence of the other. 
We used data from the Adult Psychiatric Morbidity Survey (APMS) 2007, a household survey 
conducted in England, to examine the relationship between ADHD symptoms and psychosis. 
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We tested two hypotheses: 1] Adult ADHD symptoms will be associated with psychotic 
disorder, paranoid ideation and auditory hallucinations; 2] the association between ADHD 
symptoms and psychosis will be significantly mediated by prescribed ADHD medications, use 
of illicit drugs, and dysphoric mood.  
 
2. Methods 
2.1 Setting and design 
Full details of the survey methods are available in the survey report (McManus et al., 2009). In 
brief, the sampling frame was the English Small Area Postcode Address File, and adults living 
in private households were selected using population-based multi-phase probability sampling. 
Experienced survey interviewers identified private households containing at least one person. 
They used the Kish grid method to select at random one person in each household, ensuring 
that all eligible household members had the same chance of being selected. 
In order to render the results representative of the household population in the chosen age range, 
primary sampling units were stratified by region and socioeconomic characteristics. Thus in 
each case data were weighted to take account of survey design and non-response. The sample 
sizes were designed to have the statistical power required for estimating the prevalence of less 
common disorders (0.5%-1.0%) by age, sex and region. Survey interviewers carried out Phase 
1 assessments using a detailed questionnaire that established socio-demographic 
characteristics, and covered a range of other topics. Screening procedures were applied to 
determine eligibility for the phase 2 interviews, which were carried out by clinically trained 
research interviewers.  
 
2.2 Measures 
2.2.1 Dependent variable: Measures of psychosis 
Participants were screened during phase 1 for possible psychosis, a process that included the 
Psychosis Screening Questionnaire (PSQ) (Bebbington and Nayani 1995). The PSQ comprises 
items relating to hypomanic mood, thought interference, paranoid ideation, strange 
experiences, and auditory hallucinations. Participants were invited for a phase 2 assessment if 
6 
 
they met one of the following criteria: currently on anti-psychotic medication; an inpatient stay 
for a mental or emotional problem in the past three months, or admission to a hospital or ward 
specialising in mental health problems at any time; a positive response to question 5a in the 
PSQ (this relates to auditory hallucinations); or a self-reported diagnosis of psychotic disorder 
or of symptoms suggestive of it. It was assumed that participants not meeting any of these 
criteria did not have psychosis. 
A definitive diagnosis of psychosis was made in phase 2, and was based on the Schedules for 
Clinical Assessment in Neuropsychiatry (SCAN) system (WHO 1992), a semi-structured 
clinical interview that, with its attendant algorithm, provides ICD-10 diagnoses of psychotic 
disorder. In view of the expected low prevalence of psychotic disorders, a single category was 
created corresponding to ICD-10 codes F20–F29 and those F30 codes that require psychotic 
symptoms. However, in the analyses presented here, we used a measure of “probable 
psychosis”. This category included SCAN positive cases, together with some participants who 
were not interviewed with SCAN. The latter were chosen because they met at least two of the 
phase 1 psychosis screening criteria listed above. The essential difference between the 
“psychotic disorder” and “probable psychosis” variables was that a positive diagnosis was only 
possible for ‘psychotic disorder’ if the respondent had a positive SCAN; while a positive 
diagnosis of ‘probable psychosis’ could also be made on the basis of responses to the phase 
one screening questions, where no SCAN interview was undertaken (McManus et al., 2009). 
Paranoid ideas and auditory hallucinations were coded from items from the Psychosis 
Screening Questionnaire (PSQ), which asks questions in relation to the last year. Paranoid ideas 
were measured using 3 questions and auditory hallucinations using 2 questions. These were 
coded as ordinal variables with higher scores indicating greater severity, an approach for which 
there is some previous evidence of validity (Freeman et al., 2011). Persecutory ideation was 
assessed with PSQ questions 3 (“felt that people were against you in past year?”), 3a (“felt that 
people were deliberately acting to harm you/your interests?”), and 3b (“felt group of people was 
plotting to cause you serious harm?”). Hallucinatory experiences were assessed with PSQ 
questions 5 (“heard/saw things that other people couldn’t?”) and 5a (“heard voices saying quite 
a few words or sentences?”). 
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2.2.2 Independent variable: ADHD symptoms 
Adult ADHD symptoms were measured by a face to face interview using the ADHD Self-
Report Scale (ASRS), an instrument that was developed in collaboration with the World Health 
Organisation (Adler et al., 2003). The six-item ASRS screen is a shortened version of the 18-
item Symptom Checklist scale measuring the frequency of recent DSM-IV Criterion A 
symptoms of adult ADHD. The screen is a reliable and valid measure (Kessler et al., 2007). 
There are 4 inattention and 2 hyperactivity-impulsivity items relating to the six months prior 
to interview. Respondents are asked to rate the frequency of these characteristics using a five-
point response scale: ‘never’, ‘rarely’, ‘sometimes’, ‘often’ and ‘very often’. The measure does 
not code the age of onset of the symptoms. 
We used two measures of ADHD symptoms derived from the ASRS in this analysis. Firstly 
the total ASRS score as a continuous scale was used. In order to reduce the likelihood that any 
association between ADHD symptoms and psychosis could be attributed to the former being 
an epiphenomena of psychosis we also used a measure of probable adult ADHD diagnosis. A 
score of 4 or more on the screen has a sensitivity of 68.7% and specificity of 99.5% for a 
clinical syndrome classification (Kessler et al., 2005). A score of 4 can be assumed to be an 
overestimate of the prevalence of adult ADHD diagnosis and a score of 6 an underestimate 
(McManus et al., 2009). We conservatively used a score of 6 as a measure of probable adult 
ADHD diagnosis. 
 
2.2.3 Confounders 
IQ is linked to both ADHD symptoms and psychosis. In order to control for this confounding 
effect in the analyses we used estimated verbal IQ values derived from the results of the 
National Adult Reading Test (Nelson and O'Connell 1978). 
Autistic spectrum disorder (ASD) traits were coded by the Autism-Spectrum Quotient-20 
(ASQ-20)(Baron-Cohen et al., 2001). This is a brief self-report instrument designed to assess 
the extent to which adults of normal intelligence have ASD traits. 
 
Because of the high levels of comorbidity between ADHD and externalizing disorders such as 
conduct disorder and in turn between these and psychosis we controlled for conduct problems 
before the age of 15. Scores from the 15 items related to conduct problems in the Structured 
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Clinical Interview for DSM-IV-II (SCID-II) were summed and then divided into six categories. 
These categories were endorsement of 0, 1, 2, 3, 4 items and at least 5 items endorsed. 
 
Hypomanic mood was assessed in relation to the past year in the first section of the PSQ and 
was adjusted for to ensure that any link between ADHD symptoms and psychosis was not 
simply a reflection of elated mood. 
 
Adjustment was also made for dysphoric mood (depressive and anxiety symptoms) to counter 
the argument that the ADHD symptoms picked up by the ASRS reflect symptoms that occur 
in common mental disorders. These symptoms were assessed in phase I of the survey using the 
Clinical Interview Schedule Revised (CIS–R) (Lewis et al., 1992). This is an interviewer-
administered structured schedule covering the week prior to interview. A continuous score is 
generated to indicate the extent of psychopathology. We used a binary CIS-R variable with a 
cut off of 12, which suggests significant psychopathology requiring a clinical assessment. 
 
In addition to gender, we controlled for age, employment status, marital status, and ethnic 
grouping as these might be related to both dependent and independent variables. Participants 
were divided into categories of employed, unemployed and economically inactive. Marital 
status was coded as single, married/cohabiting, divorced/separated, and widowed. Participants 
were asked to allocate themselves to an ethnic group, using the same categories as the most 
recent UK Census. Because of the relatively small numbers in most groups, categories were 
collapsed into a black group vs the remainder.  
 
2.2.4 Mediators  
 
Participants in the survey were asked whether they were prescribed Methylphenidate (Ritalin) 
or Atomoxetine (no/ yes). Illicit use of amphetamine, cocaine, or cannabis in the last year was 
recorded in the survey and coded as no / yes. 
 
Whilst depressive and anxiety symptoms were used as confounders in the regression analyses, 
we also wanted to test whether they might form part of the mechanism linking ADHD 
symptoms and psychosis. Therefore we used CIS-R score as a mediator of interest. 
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2.3 Analytic strategy 
Consistent with the wider literature, we assumed that ADHD symptoms, which start in 
childhood, precede psychosis, which usually begins in early adulthood. We use cross sectional 
data as a first approach to examining the association between ADHD symptoms and psychosis 
and potential mechanisms, given that this is a relatively new area. 
We used Stata (version 13 for MAC) to analyse weighted survey data. To assess the association 
of level of ADHD symptoms and probable ADHD with identified psychosis, paranoid ideation 
and auditory hallucinations, we used binary logistic regression, or ordered logistic regression 
as appropriate in three sets of regression analyses. Each was carried out in 4 stages designed to 
be maximally informative in relation to our hypotheses. We initially produced unadjusted odds 
ratios. We next adjusted for socio-demographic characteristics (age, sex, marital status, 
employment status, and ethnicity). Verbal IQ, ASD traits and extent of conduct problems were 
then entered into the model. Finally we adjusted for the confounding effect of hypomanic mood 
and dysphoric mood (depressive and anxiety symptoms). If at any stage adjustment resulted in 
a loss of significant association (p<0.05) we did not proceed further. 
Next, we tested whether our measures of psychosis were associated with drugs (prescribed or 
illicit) that might explain any association between ADHD and psychotic phenomenon. Data on 
use of two medicines for ADHD were available in the dataset, methylphenidate (Ritalin) and 
atomoxetine. The unadjusted association between amphetamine, cocaine and cannabis use in 
the last year with psychosis were analysed using Chi square tests. If an association emerged we 
then tested the drugs role as a mediator linking ADHD symptoms and probable ADHD 
diagnosis with psychotic phenomenon. Following this, we tested whether dysphoric mood 
mediated any link between ADHD symptoms and probable ADHD and the 3 psychosis 
variables.  
We applied the –KHB- (Karlson Holm Breen) command in Stata for these mediational 
analyses. This method decomposes the total effect of a variable into direct and indirect effects 
(Karlson et al., 2012). Confidence intervals are derived using the delta method. In these 
analyses, we controlled for the effects of confounders (IQ, ASD traits, conduct problems, 
hypomanic mood, socio-demographic variables) on the decomposition. Mediation analysis was 
only conducted for the associations between ADHD symptoms and probable ADHD, and the 
psychosis variables that were significant in our regression modelling. 
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3. Results 
The response rate of the survey was 57%, and the age range of the 7403 respondents 16-95 
years. The spread of ADHD symptoms was: 0 (38.43%), 1 (25.83%), 2 (17.46%), 3 (10.06%), 
4 (5.36%), 5 (2.30%) and 6 (0.57%). The rates of each individual ADHD symptom are 
displayed in table 1. There were 39 cases of people who scored 6 on the ASRS giving a 
prevalence of 0.53% for adult ADHD in this household survey. Other surveys have found 
prevalence rates of 2.9% (Faraone and Biederman 2005) and 4.4% (Kessler et al., 2006). This 
means that our sample of adults with an ASRS score of 6 were indeed likely to meet criteria 
for adult ADHD diagnosis. There were 27 cases of psychosis present in the last year diagnosed 
according to SCAN and 40 cases of probable psychosis (unweighted). On the basis of an ASRS 
score of 6 indicating ADHD the absolute numbers (unweighted) in each category were: no 
psychosis no ADHD: 7253, no psychosis ADHD: 35, psychosis no ADHD: 33, psychosis 
ADHD: 4. Weighted data Chi- squared test indicated p<0.0001.  
 
 
-Table 1 about here- 
 
3.1 The association between ADHD symptoms (ASRS total score), probable ADHD and 
psychosis variables 
The extent of adult ADHD symptoms was significantly associated with probable psychosis, 
paranoid ideation and auditory hallucinations (Table 2). When adjustment was made for socio 
demographic factors, verbal IQ, ASD traits, childhood conduct difficulties and, finally, 
hypomanic mood and dysphoric mood, the association was moderated. However, it remained 
statistically significant for all three response variables (all p<0.05). Probable ADHD caseness 
was significantly associated with the psychosis variable after adjustment for the numerous 
confounders. It did not however remain significantly associated with paranoid thinking or 
auditory hallucinations specifically after adjustment. We completed post-hoc regression 
modelling using the ASRS cut off of 5 plus, the rationale being that this approximates to a 
prevalence of ADHD caseness of 2.87%, similar to the figure of 2.9% found by Faroane and 
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Biederman (Faraone and Biederman 2005). Using this ASRS cut off there was no significant 
association (p=0.469) between ADHD caseness and probable psychotic illness once adjustment 
was made for confounders. The adjusted associations between ASRS score 5 plus were 
significant with paranoid ideation (p=0.001) and auditory hallucinations (p=0.014). 
 
-Table 2 about here- 
 
3.2 Mediational analyses 
Only 2 people (age 16 and over) in the survey mentioned taking Ritalin, with one of these 
scoring above the 4 cut off (normally used to indicate a clinical assessment is needed) in the 
ASRS. Only 1 person was taking Atomoxetine and they had an ASRS score of below 4. Further 
analyses of these particular variables were therefore inappropriate. 
The weighted counts of people using cocaine, cannabis or amphetamines in the last year were 
182.8, 549.2 and 54.4 respectively The illicit use of amphetamines in the last 12 months was 
significantly associated with paranoid ideation (p<0.001) but not with auditory hallucinations 
(p=0.29) or probable psychosis (p=0.17). Cocaine use was also only significantly associated 
with paranoid ideation (p<0.001), not with auditory hallucinations (p=0.26) or probable 
psychosis (p=0.07). Cannabis use in the last year was significantly associated with all three 
measures of psychosis: probable psychosis (p=0.049), paranoid ideation (p<0.001) and 
auditory hallucinations (p<0.002). In accord with our analysis plan, we carried out mediational 
analyses on the significant associations of individual drugs of abuse and measures of psychosis 
in this unadjusted analysis. No type of illicit drug use mediated the association between ASRS 
total score, and the psychosis variables. The results of these analyses are shown in table 3 
 
-Table 3 about here- 
 
In contrast dysphoric mood did mediate the link between ADHD symptoms and psychosis, 
paranoid ideation and auditory hallucinations. It explained 23%, 23% and 11% of the links 
12 
 
respectively. Dysphoric mood explained 31% of the link between probable ADHD diagnosis 
and psychosis. The results of these mediational analyses are shown in table 4. 
 
-Table 4 about here- 
 
4. Discussion 
4.1 Main findings 
We tested hypotheses regarding the association between the extent of ADHD symptoms, 
probable adult ADHD and psychosis, and examined potential underlying mechanisms. The 
main findings were that higher levels of ADHD symptoms in adults were associated with 
psychosis, paranoid ideation and auditory hallucinations. Probable ADHD caseness (ASRS = 
6) is associated with probable psychosis only. This persisted even when we controlled for the 
confounding effects of IQ, childhood conduct problems, features of ASD and hypomanic and 
dysphoric mood, suggesting the association is robust, although fairly modest. Our post-hoc 
analyses using an ASRS score of 5 and above indicated that there was a significant association 
between ADHD caseness and paranoid ideation, and auditory hallucinations, but not with 
probable psychosis. This suggests it is only a high ADHD symptom load that is important in 
explaining the associations with a psychotic illness. 
 
Very few adults with ADHD symptoms were taking prescribed drugs used in the treatment of 
ADHD such as Ritalin and Atomoxetine. This is an important clinical issue in its own right. 
We were not able to statistically test whether use of these medications is a significant 
mechanism underlying the link that was found. However at a population level the link exists 
even in the absence of the use of these medications. The association between ADHD 
symptoms, probable ADHD and psychosis, paranoia and auditory hallucinations is not 
mediated by the abuse of drugs such as amphetamines, cocaine or cannabis. We did however 
find that dysphoric mood is likely to form part of the pathway between higher ADHD symptom 
load in adults and psychosis. 
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4.2 Limitations 
We used a self-report assessment scale, the ASRS, to measure ADHD symptomatology and a 
probable diagnosis of ADHD. No clinical assessment incorporating diagnostic criteria and 
functional consequences of symptoms followed the administration of the screen and we 
therefore cannot be sure about a connection between diagnosed ADHD and psychosis. We did 
however use a cut off score of 6 on the ASRS to indicate probable ADHD diagnosis which 
appears to give a conservative estimate of clinical diagnosis. Never the less our findings should 
be considered preliminary. Attention deficit hyperactivity disorder is considered dimensional 
in nature, predisposing to a range of poor outcomes (Shah and Morton 2013); secondly, 
symptomatic persistence is greater than syndromal persistence of childhood ADHD into 
adulthood (Faraone et al., 2000). Both of these factors support our analytic approach and the 
utility of our findings, but further studies of diagnosed ADHD are needed in future research. 
We decided to use the “probable psychosis” variable as opposed the “psychotic disorder” 
variable as coded by the SCAN. The main APMS report explains 75% of men and 59% of 
women meeting two or more psychosis screening criteria at phase one were assessed by SCAN 
as negative for psychosis. While psychotic disorder uses a weighting strategy, probable 
psychosis assigns an outcome according to phase one screening criteria. (McManus et al., 
2009). It is also the case that some of the Screen Positive Scan Negative group are likely to be 
people with psychosis on medication and without current symptoms 
 
Using the SCAN psychosis group, because of the smaller sample makes looking at the 
characteristics of this group problematic. The use of “probable psychosis” results in an entirely 
plausible prevalence of 0.5%, which is quite close to the weighted prevalence of psychotic 
disorder obtained using the SCAN. The probable psychosis variable has been used in many and 
varied analyses (Bebbington et al., 2004, Brugha et al., 2004, Marwaha et al., 2014, Catone et 
al., 2015). Finally Qassem et al (Qassem et al., 2014) show the close correspondence in all 
demographic associations between “probable psychosis” and SCAN psychosis, based on 
amalgamated data from all three psychiatric morbidity surveys. For all these reasons, we, a 
priori decided to use the probable psychosis variable. 
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Levels of psychotic symptoms as indexed by self-report measures administered in population 
surveys are very high and do not necessarily mean that a psychotic disorder is present (Kelleher 
et al., 2012). Our results should be interpreted in this context. 
 
The numbers using amphetamines in the last year were relatively modest and therefore it is 
possible that we did not find an association between this use and auditory hallucinations or 
probable psychosis when one exists, though it seems unlikely that this would influence our 
main findings. The APMS is a cross sectional population survey, so inferences about causal 
directions and temporal precedence must be tentative. However, our analysis did not refute the 
possible role of affect in mediating the associations between extent of ADHD symptoms and 
psychotic phenomenon. It is possible that dysphoric mood is a severity indicator and further 
research using prospective data is required to confirm our findings. 
 
4.3 Implications 
This study is the first to use representative national survey data to test putative associations 
between ADHD and psychosis. It has been argued that major mental illnesses can be ordered 
based on the level of neurodevelopmental dysfunction, from intellectual disability at one pole, 
to autism, ADHD, schizophrenia and bipolar disorder (Owen et al., 2011). This hierarchy 
implies that the association between ADHD symptoms and psychosis might be specific. 
Alternatively given the risk of psychosis conferred by autistic spectrum disorder (Cheung et 
al., 2010), ADHD might form part of a common neurodevelopmental spectrum that predisposes 
to psychosis given a combination of psychosocial factors. However, our findings suggest a 
more specific association, given that the ADHD-psychosis link was robust after accounting for 
the effects of IQ and ASD. 
A recent confirmatory factor analysis of psychopathology data from the Dunedin Multi-
disciplinary Health and Development study suggests that psychiatric disorders overlap to a 
large extent (Caspi et al., 2013) and might be categorized by a general psychopathology factor 
(p factor), as well as internalizing and externalizing factors. One potential interpretation of our 
findings is therefore that ADHD symptoms and psychoses are simply overlapping constructs. 
However both disorders share a small but significant genetic vulnerability through rare 
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chromosomal variants (Williams et al., 2010) as well as common single nucleotide 
polymorphisms (Hamshere et al., 2013).  
 
The modest effect size in our population level analyses is consistent with this genetic evidence. 
It has been argued that the genetic architecture of ADHD shows a greater link with 
schizophrenia than with bipolar disorder (Hamshere et al., 2013), despite the strong body of 
evidence for comorbidity between ADHD and bipolar disorder (Wingo and Ghaemi 2007). 
How this genetic variation confers risk to both disorders is as yet unknown. The underlying 
shared biology may relate to the dopaminergic system with hyperactivity and hypoactivity in 
these systems in psychosis and ADHD (Levy and Swanson 2001) respectively. Reconciling 
these opposite findings in neuroimaging studies has led researchers to suggest that both 
disorders fall on a single continuum of dopaminergic imbalance (Barr 2001, Mehler-Wex et 
al., 2006). 
 
Both those at risk of psychosis, and those who have already developed it, have impairments 
similar to those seen in ADHD in experimental tests of attention, and these may predict 
transition to first episode (Pukrop and Klosterkötter 2010). The precise mechanism by which 
impaired attention causes this risk is not clear; it may be as a vulnerability factor or by 
impacting on cognitive processes. Whilst it is not regarded as a core feature, patients with 
schizophrenia have been found to be more impulsive than controls using event-related 
functional magnetic resonance imaging (Kaladjian et al., 2011), and this impulsivity is 
especially associated with aggression (Hoptman et al., 2010). Our main results are consistent 
with this previous evidence. 
 
The majority of children with ADHD will not have the syndrome in adolescence (Gau et al., 
2010) or adulthood, and hyperactive-impulsive symptoms diminish with time at a greater rate 
than those of inattention (Biederman et al., 2000). This implies the link with psychosis may be 
a function of severity and persistence of ADHD symptoms into adulthood. In other words, 
those with a more serious form of the disorder have persisting symptoms, and form the main 
sub-population at higher risk of psychosis. In part, this last finding could be explicable by 
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higher attention deficit and hyperactivity-impulsivity levels leading to a greater degree of 
aversive consequences over time, but we could not test for this specifically.  
 
Factors associated with ADHD include peer victimization, abuse, social deprivation, and 
educational failure (Washbrook et al., 2013). These are also features of people with 
schizophrenia and those at risk of psychosis (Fisher et al., 2010). Both disorders therefore share 
common psychological and social risk factors. It is notable that many of these factors are also 
associated with dysphoric mood, which, we found forms part of the pathway between ADHD 
symptoms and psychotic phenomenon. Disentangling and understanding the relative effects of 
these risk factors and of anxiety and depression as well as other mediators, will require analyses 
of prospective longitudinal cohorts utilising structural equation modelling. 
 
The association between ADHD symptoms and psychosis has treatment implications. There is 
under-treatment of ADHD in adults (Bolea-Alamañac et al., 2014), and this links to the very 
low ADHD medication use reported in this study. It is likely that this issue extends to the 
treatment of the syndrome when comorbid with psychosis. This is important, given that 
comorbidity with other psychiatric disorders worsens the outcome both for ADHD (Miller et 
al., 2007) and for psychosis (Sim et al., 2006). Given our findings, it is possible that treatment 
of ADHD might modify psychotic symptoms when the conditions are comorbid. In planning 
treatment, clinicians should not assume that the major reason for people with ADHD 
developing psychosis is illicit use of cocaine, amphetamine or cannabis. Our analyses directly 
contradict this view. Given the mediational link, it is important to treat anxiety and depression 
in adults with ADHD, not only to reduce the morbidity associated with these disorders, but also 
because this may afford some protection against psychosis and in particular paranoid thinking. 
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Table 1: Responses (%) to individual ASRS questions (weighted) 
 Adult ADHD self report scale 
 
 “How often do you 
have trouble 
wrapping up the fine 
details of a project 
once the challenging 
parts have been 
done?”  
% 
 
How often do you 
have difficulty 
getting things in 
order when you 
have to do a task 
that requires 
organization? 
% 
How often to do 
you have problems 
remembering 
appointments or 
obligations 
% 
When you have a 
task that requires a 
lot of thought, how 
often do you avoid 
or delay getting 
started? 
% 
How often do you 
fidget or squirm 
with your hands or 
your feet when you 
have to sit down 
for a long time? 
% 
How often do you 
feel overly active 
and compelled to 
do things, like you 
were driven by a 
motor? 
% 
Never 
 
42.69 45.16 38.43 30.19 32.76 39.24 
Rarely 
 
29.79 33.5 32.6 28.12 20.75 25.57 
Sometimes 
 
19.89 16.11 20.1 29.58 21.71 22.28 
Often 
 
5.78 3.96 6.38 9.41 16.13 9.52 
Very often 
 
1.85 1.26 2.48 2.71 8.66 3.39 
% with responses 
indicating symptom 
is significant* 
 
27.52 
 
21.33 
 
28.96 
 
12.12 
 
24.79 
 
12.91 
 
*symptom significance as indicated by previously used cut-offs (McManus et al., 2009) 
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Table 2: The cross-sectional association between ADHD symptoms and psychosis and 
psychotic symptoms 
 ASRS continuous score 
 
ASRS score = 6 
Probable psychosis 
 
 Odds ratio 
(95% 
confidence 
limits) 
t p>t Odds ratio 
(95% 
confidence 
limits) 
 
t p>t 
Unadjusted 
 
1.31 (1.22-
1.41) 
7.22 <0.001 
 
29.28 (8.10-
105.83) 
5.17 <0.001 
Controlling for 
socio-
demographic 
variables 1 
1.28 (1.19-
1.38) 
6.41 <0.001 16.59 (4.52-
60.85) 
4.26 <0.001 
Controlling for 
the above plus 
estimated verbal 
IQ, ASD score 
and conduct 
problems score 
1.19 (1.10-
1.29) 
4.42 <0.001 6.76 (1.56-
29.33) 
2.46 0.011 
Controlling for 
the above plus 
hypomanic and 
dysphoric mood 
 
1.12 (1.04-
1.22) 
2.85 0.005 4.25 (1.06-
16.95) 
2.06 0.041 
 
Paranoid ideation 
 Odds ratio 
(95% 
confidence 
limits) 
t p>t Odds ratio 
(95% 
confidence 
limits) 
t p>t 
Unadjusted 
 
1.22 (1.20-
1.24) 
23.50 <0.001 5.56 (3.02-
10.24) 
5.54 <0.001 
Controlling for 
socio-
demographic 
variables 1 
1.20 (1.18-
1.23) 
20.29 <0.001 4.94 (2.60-
9.40) 
4.90 <0.001 
Controlling for 
the above plus 
estimated verbal 
IQ, ASD score 
and conduct 
problems score 
1.17 (1.14-
1.19) 
16.36 <0.001 2.98 (1.58-
6.01) 
3.08 0.002 
Controlling for 
the above plus 
1.12 (1.10-
1.14) 
11.13 <0.001 1.61 (0.86-
3.00) 
1.51 0.133 
24 
 
hypomanic and 
dysphoric mood 
 
 
Auditory hallucinations 
   
 Odds ratio 
(95% 
confidence 
limits) 
t p>t Odds ratio 
(95% 
confidence 
limits) 
t p>t 
Unadjusted 
 
1.19 (1.16-
1.23) 
12.40 <0.001 3.18 (1.04-
9.71) 
2.04 0.043 
Controlling for 
socio-
demographic 
variables 1 
1.18 (1.15-
1.21) 
11.94 <0.001 2.55 (0.83-
7.85) 
1.64 0.102 
Controlling for 
the above plus 
estimated verbal 
IQ, ASD score 
and conduct 
problems score 
1.14 (1.10-
1.18) 
8.18 <0.001  
*** 
 
*** 
 
*** 
Controlling for 
the above plus 
hypomanic and 
dysphoric mood 
1.11 (1.08-
1.15) 
6.45 <0.001  
*** 
 
*** 
 
*** 
 
1 age, sex, marital status, employment status and ethnicity 
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Table 3: Illicit drug use as mediators of the link between the ADHD symptoms and 
psychotic phenomenon in adults 
Amphetamine use 
Paranoid ideation 
Effect OR Robust 
standard 
error 
Z P>z 95% CI 
Total 1.16 0.01 15.18 <0.001 1.14-1.18 
Direct  1.16 0.01 15.18 <0.001 1.03-1.19 
Indirect 1.00 0.0002 1.08 0.279 1.00-1.00 
Cocaine use 
Paranoid ideation 
Effect OR Robust 
standard 
error 
Z P>z 95% CI 
Total  1.16 0.01 15.56 <0.001 1.14-1.19 
Direct  1.16 0.01 15.55 <0.001 1.14-1.86 
Indirect  1.00 0.0001 0.00 0.996 1.00-1.00 
Cannabis use 
Probable psychosis (ASRS continuous score) 
Effect OR Robust 
standard 
error 
Z P>z 95% CI 
Total  1.18 0.04 4.55 <0.001 1.10-1.27 
Direct  1.18 0.04 4.58 <0.001 1.10- 1.26 
Indirect  1.00 0.003 0.52 0.602 1.00-1.00 
 
Probable psychosis (ASRS score = 6) 
Total 5.96 3.76 2.82 0.005 1.73-20.54 
Direct 5.87 3.69 2.81 0.005 1.71-20.16 
Indirect 1.01 0.04 0.36 0.718 0.94-1.09 
Paranoid ideation 
Effect OR Robust 
standard 
error 
Z P>z 95% CI 
Total  1.16 0.01 15.46 <0.001 1.14-1.19 
Direct  1.16 0.01 15.24 <0.001 1.14-1.18 
Indirect  1.00 0.0007 1.35 0.177 1.00-1.00 
Auditory hallucination 
Effect OR Robust 
standard 
error 
Z P>z 95% CI 
Total 1.14 0.02 7.39 <0.001 1.10-1.18 
Direct 1.14 0.02 7.35 <0.001 1.10-1.18 
Indirect 1.00 0.001 0.05 0.958 1.00-1.00 
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Table 4: Dysphoric mood (depression and anxiety) as a mediator of the link between 
ADHD symptoms and psychotic phenomena in adults 
Dysphoric mood 
Probable psychosis (ASRS continuous score) 
Effect OR Robust 
standard 
error 
Z P>z 95% CI 
Total 
 
1.16 0.04 4.18 <0.001 1.08-1.25 
Direct  
 
1.12 0.04 3.16 0.002 1.04-1.21 
Indirect 
 
1.03 0.01 3.34 0.001* 1.01-1.06 
22.93% of the link mediated 
Probable psychosis (ASRS score = 6) 
Total 8.14 4.95 3.45 0.001 2.47 - 26.80 
 
Direct 4.25 2.49 2.47 0.014 1.35 - 13.39 
 
Indirect 1.91 0.43 2.93 0.003 1.24 - 2.96 
 
31.04 % of the link mediated 
Paranoid ideation 
Effect OR Robust 
standard 
error 
Z P>z 95% CI 
Total  
 
1.16 0.01 14.69 <0.001 1.13-1.18 
Direct  
 
1.12 0.01 10.94 <0.001 1.10-1.14 
Indirect  1.03 0.003 11.07 <0.001* 1.03-1.04 
 
22.90% of the link mediated 
Auditory hallucination 
Effect OR Robust 
standard 
error 
Z P>z 95% CI 
Total 
 
1.13 0.02 7.13 <0.001 1.09-1.17 
Direct 
 
1.11 0.02 6.04 <0.001 1.08-1.16 
Indirect 
 
1.01 0.004 3.10 0.002* 1.00-1.02 
10.85 % of the link mediated 
*indicates dysphoric mood as a significant mediator after controlling for socio-demographic 
variables, verbal IQ, ASD traits, childhood conduct problems and hypomanic mood 
